Literature DB >> 26316599

The Choice of Analytical Strategies in Inverse-Probability-of-Treatment-Weighted Analysis: A Simulation Study.

Shibing Yang, Juan Lu, Charles B Eaton, Spencer Harpe, Kate L Lapane.   

Abstract

We sought to explore the impact of intention to treat and complex treatment use assumptions made during weight construction on the validity and precision of estimates derived from inverse-probability-of-treatment-weighted analysis. We simulated data assuming a nonexperimental design that attempted to quantify the effect of statin on lowering low-density lipoprotein cholesterol. We created 324 scenarios by varying parameter values (effect size, sample size, adherence level, probability of treatment initiation, associations between low-density lipoprotein cholesterol and treatment initiation and continuation). Four analytical approaches were used: 1) assuming intention to treat; 2) assuming complex mechanisms of treatment use; 3) assuming a simple mechanism of treatment use; and 4) assuming invariant confounders. With a continuous outcome, estimates assuming intention to treat were biased toward the null when there were nonnull treatment effect and nonadherence after treatment initiation. For each 1% decrease in the proportion of patients staying on treatment after initiation, the bias in estimated average treatment effect increased by 1%. Inverse-probability-of-treatment-weighted analyses that took into account the complex mechanisms of treatment use generated approximately unbiased estimates. Studies estimating the actual effect of a time-varying treatment need to consider the complex mechanisms of treatment use during weight construction.
© The Author 2015. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  as-treated analysis; data simulation; intention to treat; marginal structural models

Mesh:

Substances:

Year:  2015        PMID: 26316599      PMCID: PMC4564939          DOI: 10.1093/aje/kwv098

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  31 in total

1.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

2.  Marginal structural models to estimate the causal effect of zidovudine on the survival of HIV-positive men.

Authors:  M A Hernán; B Brumback; J M Robins
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

3.  Marginal structural models and causal inference in epidemiology.

Authors:  J M Robins; M A Hernán; B Brumback
Journal:  Epidemiology       Date:  2000-09       Impact factor: 4.822

4.  Effects of glucosamine and chondroitin supplementation on knee osteoarthritis: an analysis with marginal structural models.

Authors:  Shibing Yang; Charles B Eaton; Timothy E McAlindon; Kate L Lapane
Journal:  Arthritis Rheumatol       Date:  2015-03       Impact factor: 10.995

Review 5.  Adherence to medication.

Authors:  Lars Osterberg; Terrence Blaschke
Journal:  N Engl J Med       Date:  2005-08-04       Impact factor: 91.245

Review 6.  Application of marginal structural models in pharmacoepidemiologic studies: a systematic review.

Authors:  Shibing Yang; Charles B Eaton; Juan Lu; Kate L Lapane
Journal:  Pharmacoepidemiol Drug Saf       Date:  2014-01-24       Impact factor: 2.890

7.  The lipid treatment assessment project (L-TAP): a multicenter survey to evaluate the percentages of dyslipidemic patients receiving lipid-lowering therapy and achieving low-density lipoprotein cholesterol goals.

Authors:  T A Pearson; I Laurora; H Chu; S Kafonek
Journal:  Arch Intern Med       Date:  2000-02-28

Review 8.  Beyond intention to treat: what is the right question?

Authors:  Ian Shrier; Russell J Steele; Evert Verhagen; Rob Herbert; Corinne A Riddell; Jay S Kaufman
Journal:  Clin Trials       Date:  2013-10-03       Impact factor: 2.486

9.  Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count.

Authors:  Stephen R Cole; Miguel A Hernán; Joseph B Margolick; Mardge H Cohen; James M Robins
Journal:  Am J Epidemiol       Date:  2005-08-02       Impact factor: 4.897

10.  Apparent discontinuation rates in patients prescribed lipid-lowering drugs.

Authors:  L A Simons; G Levis; J Simons
Journal:  Med J Aust       Date:  1996-02-19       Impact factor: 7.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.